Key points are not available for this paper at this time.
New technologies can revolutionize influenza vaccine design, production, and delivery. In the near future, advances should reduce vaccine production time, provide enhanced protection, and end mismatches between vaccine strains and circulating viruses.
Lambert et al. (Wed,) studied this question.